Corcept Therapeutics reported $27.41M in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
Ardelyx ARDX:US $ -26.94M 1.13M
Aurora Cannabis Inc ACB:CN -618787000 393.39M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Bristol Myers Squibb BMY:US $ 1421M 143M
Canopy Growth Corp WEED:CN C$ -2083148000 1.51B
Corcept Therapeutics CORT:US $ 27.41M 4.62M
Depomed DEPO:US $ 7.83M 1.23M
Eleven Biotherapeutics EBIO:US $ -0.81M 9.75M
Eli Lilly And LLY:US $ 952.5M 950.4M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Johnson & Johnson JNJ:US $ 4814M 335M
Knight Therapeutics Inc GUD:CN C$ 2.52M 21.33M
Lannett LCI:US $ -93.3M 58.4M
Lexicon Pharmaceuticals LXRX:US $ -24.59M 1.11M
Merk MRK:US $ 3944M 366M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Novartis NOVN:VX SF 1694M 528M
Novartis NVS:US $ 1694M 528M
Omeros OMER:US $ -30849000 2.16M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Pfizer PFE:US $ 9905M 2042M
Supernus Pharmaceuticals SUPN:US $ 7.86M 17.75M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Ziopharm Oncology ZIOP:US $ -9.93M 0.14M